Resultats de la cerca - David Paul Jenkins

  • Mostrar 1 - 1 resultats de 1
Refinar resultats
  1. 1
    Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept

    Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept per Izumi Maezawa, Hai M. Nguyen, Jacopo Di Lucente, David Paul Jenkins, Vikrant Singh, Silvia Hilt, Kyoungmi Kim, Srikant Rangaraju, Allan I. Levey, Heike Wulff, Lee‐Way Jin

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: